235 related articles for article (PubMed ID: 32561567)
1. IL-25 Receptor Signaling Modulates Host Defense against
Hansakon A; Jeerawattanawart S; Pattanapanyasat K; Angkasekwinai P
J Immunol; 2020 Aug; 205(3):674-685. PubMed ID: 32561567
[TBL] [Abstract][Full Text] [Related]
2. STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformans.
Leopold Wager CM; Hole CR; Wozniak KL; Olszewski MA; Mueller M; Wormley FL
Infect Immun; 2015 Dec; 83(12):4513-27. PubMed ID: 26351277
[TBL] [Abstract][Full Text] [Related]
3. STAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice.
Leopold Wager CM; Hole CR; Wozniak KL; Olszewski MA; Wormley FL
J Immunol; 2014 Oct; 193(8):4060-71. PubMed ID: 25200956
[TBL] [Abstract][Full Text] [Related]
4. Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Thailand display diverse phenotypic interactions with macrophages.
Hansakon A; Mutthakalin P; Ngamskulrungroj P; Chayakulkeeree M; Angkasekwinai P
Virulence; 2019 Dec; 10(1):26-36. PubMed ID: 30520685
[TBL] [Abstract][Full Text] [Related]
5. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis.
Wozniak KL; Ravi S; Macias S; Young ML; Olszewski MA; Steele C; Wormley FL
PLoS One; 2009 Sep; 4(9):e6854. PubMed ID: 19727388
[TBL] [Abstract][Full Text] [Related]
6. CARD9 Is Required for Classical Macrophage Activation and the Induction of Protective Immunity against Pulmonary Cryptococcosis.
Campuzano A; Castro-Lopez N; Martinez AJ; Olszewski MA; Ganguly A; Leopold Wager C; Hung CY; Wormley FL
mBio; 2020 Jan; 11(1):. PubMed ID: 31911495
[TBL] [Abstract][Full Text] [Related]
7. Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99.
Zhang Y; Wang F; Tompkins KC; McNamara A; Jain AV; Moore BB; Toews GB; Huffnagle GB; Olszewski MA
Am J Pathol; 2009 Dec; 175(6):2489-500. PubMed ID: 19893050
[TBL] [Abstract][Full Text] [Related]
8. Enhanced innate immune responsiveness to pulmonary Cryptococcus neoformans infection is associated with resistance to progressive infection.
Guillot L; Carroll SF; Homer R; Qureshi ST
Infect Immun; 2008 Oct; 76(10):4745-56. PubMed ID: 18678664
[TBL] [Abstract][Full Text] [Related]
9. Effect of cytokine interplay on macrophage polarization during chronic pulmonary infection with Cryptococcus neoformans.
Arora S; Olszewski MA; Tsang TM; McDonald RA; Toews GB; Huffnagle GB
Infect Immun; 2011 May; 79(5):1915-26. PubMed ID: 21383052
[TBL] [Abstract][Full Text] [Related]
10. T Cell-Restricted Notch Signaling Contributes to Pulmonary Th1 and Th2 Immunity during
Neal LM; Qiu Y; Chung J; Xing E; Cho W; Malachowski AN; Sandy-Sloat AR; Osterholzer JJ; Maillard I; Olszewski MA
J Immunol; 2017 Jul; 199(2):643-655. PubMed ID: 28615417
[No Abstract] [Full Text] [Related]
11. Arginase inhibitor reduces fungal dissemination in murine pulmonary cryptococcosis by promoting anti-cryptococcal immunity.
Hansakon A; Angkasekwinai P
Int Immunopharmacol; 2024 May; 132():111995. PubMed ID: 38581993
[TBL] [Abstract][Full Text] [Related]
12. Cytokine and chemokine expression in the central nervous system associated with protective cell-mediated immunity against Cryptococcus neoformans.
Uicker WC; Doyle HA; McCracken JP; Langlois M; Buchanan KL
Med Mycol; 2005 Feb; 43(1):27-38. PubMed ID: 15712606
[TBL] [Abstract][Full Text] [Related]
13. Th2 but not Th1 immune bias results in altered lung functions in a murine model of pulmonary Cryptococcus neoformans infection.
Jain AV; Zhang Y; Fields WB; McNamara DA; Choe MY; Chen GH; Erb-Downward J; Osterholzer JJ; Toews GB; Huffnagle GB; Olszewski MA
Infect Immun; 2009 Dec; 77(12):5389-99. PubMed ID: 19752036
[TBL] [Abstract][Full Text] [Related]
14. Macrophage-Derived Osteopontin Influences the Amplification of
Hansakon A; Png CW; Zhang Y; Angkasekwinai P
J Immunol; 2021 Oct; 207(8):2107-2117. PubMed ID: 34526375
[TBL] [Abstract][Full Text] [Related]
15. IL-33 signaling regulates innate and adaptive immunity to Cryptococcus neoformans.
Flaczyk A; Duerr CU; Shourian M; Lafferty EI; Fritz JH; Qureshi ST
J Immunol; 2013 Sep; 191(5):2503-13. PubMed ID: 23894196
[TBL] [Abstract][Full Text] [Related]
16. Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans.
Beenhouwer DO; Shapiro S; Feldmesser M; Casadevall A; Scharff MD
Infect Immun; 2001 Oct; 69(10):6445-55. PubMed ID: 11553589
[TBL] [Abstract][Full Text] [Related]
17. Abrogation of IL-4 receptor-α-dependent alternatively activated macrophages is sufficient to confer resistance against pulmonary cryptococcosis despite an ongoing T(h)2 response.
Müller U; Stenzel W; Piehler D; Grahnert A; Protschka M; Köhler G; Frey O; Held J; Richter T; Eschke M; Kamradt T; Brombacher F; Alber G
Int Immunol; 2013 Aug; 25(8):459-70. PubMed ID: 23532373
[TBL] [Abstract][Full Text] [Related]
18. Role of IL-17A on resolution of pulmonary C. neoformans infection.
Wozniak KL; Hardison SE; Kolls JK; Wormley FL
PLoS One; 2011 Feb; 6(2):e17204. PubMed ID: 21359196
[TBL] [Abstract][Full Text] [Related]
19. Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection.
Davis MJ; Tsang TM; Qiu Y; Dayrit JK; Freij JB; Huffnagle GB; Olszewski MA
mBio; 2013 Jun; 4(3):e00264-13. PubMed ID: 23781069
[TBL] [Abstract][Full Text] [Related]
20. Stimulation via Toll-like receptor 9 reduces Cryptococcus neoformans-induced pulmonary inflammation in an IL-12-dependent manner.
Edwards L; Williams AE; Krieg AM; Rae AJ; Snelgrove RJ; Hussell T
Eur J Immunol; 2005 Jan; 35(1):273-81. PubMed ID: 15597328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
